Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells

Blood

Volumn 91, Issue 1, 1998, Pages 196-206

  Geldhof, Anja B ^a   Moser, Muriel ^b   Lespagnard, Laurence ^b   Thielemans, Kris ^b   De Baetselier, Patrick ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 2;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; DENDRITIC CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; TARGET CELL; TUMOR CELL CULTURE;

EID: 0031965580     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.196     Document Type: Article

References (60)

1. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187, 1989
2. Raulet DH: Recognition events that inhibit and activate natural killer cells. Curr Opin Immun 8:372, 1996
3. Karlhofer FM, Yokoyama WM: Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways. J Immunol 146:3662, 1991
4. Kaufman DS, Schoon RA, Robertson MJ, Leibson PJ: Inhibition of selective signalling events in natural killer cells recognizing major histocompatibility complex class I. Proc Nad Acad Sci USA 92:6484, 1995
5. Ljunggren HG, Karre K: In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11:237, 1990
6. k antigens. Int J Cancer 58:217, 1994
7. k and concomitant enhanced metastasis. Cancer Immunol Immunother 42: 329, 1996
8. Karre K, Ljunggren HG, Piontek G, Kiessling R: Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675, 1986
9. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P: NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 138:1657, 1987
10. Ohlen C, Kling G, Höglund P, Hansson M, Scangos G, Bieberich C, Jay G, Karre K: Prevention of allogeneic bone marrow graft rejection by H-2 transgene in donor mice. Science 246:666, 1989
11. Liao N, BiX H, Zijlstra M, Jaenisch R, Raulet D: MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199, 1991
12. Ciccone E, Pende D, Viale O, Than A, Di Donato C, Orengo AM, Biassoni R, Verdiani S, Amoroso A, Moretta A, Moretta L: Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: Expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J Exp Med 176:963, 1992
13. + IL-2 activated natural killer cells. Nature 358:66, 1992
14. Daniels BF, Karlhofer FM, Seaman WE, Yokoyama WM: A natural killer cell receptor specific for a major histocompatibility complex class I molecule. J Exp Med 180:687, 1994
15. Stoneman ER, Bennett M, An J, Chesnut KA, Wakeland EK, Scheerer JB, Siciliano MJ, Kumar V, Mathew PA: Cloning and characterization of 5E6 (Ly49C), a receptor molecule expressed on a subset of murine natural killer cells. J Exp Med 182:305, 1995
16. Mason LH, Ortaldo JR, Young HA, Kumar V, Bennett M, Anderson SK: Cloning and functional characteristics of murine LGL-1: A member of the Ly-49 gene family (Ly-49G2). J Exp Med 182:293, 1995
17. Wagtmann N, Biasonni R, Cantoni C, Verdiani S, Malnati M, Vitale M, Bottino C, Moretta L, Moretta A, Long E: Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intra-cellular domains. Immunity 2:439, 1995
18. Colonna M, Samaridis J: Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268:405, 1995
19. D'Andrea A, Chang C, Bacon K, McClanahan T, Phillips J, Lanier LL: Molecular cloning of NKB1: A natural killer cell receptor for HLA-B allotypes. J Immunol 155:2306, 1995
20. Correa L, Corral L, Raulet DH: Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur J Immunol 24:1323, 1994
21. Chervenak R, Wolcott RM: Target cell expression of MHC antigens is not (always) a turn-off signal to natural killer cells. J Immunol 140:3712, 1988
22. Sawada Y, Fohring B, Shenk TE, Raska K Jr: Tumorigenicity of adenovirus-transformed cells: Region E1A of adenovirus 12 confers resistance to natural killer cells. Virology 147:413, 1985
23. Shah PD, Gilbertson SM, Rowley DA: Dendritic cells that have interacted with antigen are targets for natural killer cells. J Exp Med 162:625, 1985
24. Geldhof AB, Raes G, Bakkus M, Devos S, Thielemans K, De Baetselier P: Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res 55:2730, 1995
25. Yeh K-Y, Pulaski BA, Woods ML, McAdam AJ, Gaspari AA, Frelinger JG, Lord EM: B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell Immunol 165:217, 1995
26. Wu T-C, Huang AYC, Jaffee EM, Levitsky HI, Pardoll DM: A reassessment of the role of B7-1 expression in tumor rejection. J Exp Med. 182:1415, 1995
27. Chambers BJ, Salcedo M, Ljunggren H-G: Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5:311, 1996
28. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSE), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170:827, 1989
29. Stern AS, Podlaski FJ, Hulmes JD, Pan YE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizonnite R, Gately MK: Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87:6808, 1990
30. + NK cells. J Immunol 148:2429, 1992
31. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J: Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 175:779, 1992
32. Rabinowich H, Herberman RB, Whiteside TL: Differential effects of IL12 and IL2 on expression and function of cellular adhesion molecules on purified human natural killer cells. Cell Immunol 152:481, 1993
33. Kubin M, Kamoun M, Trinchieri G: Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 180:211, 1994
34. Coughlin CM, Wysocka M, Kurzawa HL, Lee WMF, Trinchieri G, Eck SL: B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res 55:4980, 1995
35. Zitvogel L, Robbins PD, Storkus WJ, Clarke MR, Maeurer MJ, Campbell RL, Davis CG, Tahara H, Schreiber RD, Lotze MT: Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur J Immunol 26:1335, 1996
36. Shahinian A, Pfeffer K, Lee KP, Kündig TM, Kishihara K, Wakeham A, Kawai K, Ohashi PS, Thompson CB, Mak TW: Differential T cell costimulatory requirements in CD28-deficient mice. Science 261:609, 1993
37. Belloni M, Iezzi G, Manfredi AA, Protti MP, Dellabona P, Casorati G, Rugarli C: In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Eur J Immunol 24:2691, 1994
38. Crowley M, Inaba K, Witmer-Pack M, Steinman RM: The cell surface of mouse dendritic cells: FACS analyses of dendritic cells from different tissues including thymus. Cell Immunol 118:108, 1989
39. Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, Steinman RM: The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med 171:1753, 1990
40. Inaba K, Inaba M, Romani M, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony stimulating factor. J Exp Med 176:1693, 1992
41. Brunda MJ, Luistro L, Hendrzak JA, Fountoulakis M, Garotta G, Gately MK: Role of interferon-γ in mediating the antitumor efficacy of interleukin-12. J Immunother 17:71, 1995
42. Tannenbaum CS, Wicker N, Armstrong D, Tubbs R, Finke J, Bukowski RM, Hamilton TA: Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J Immunol 156:693, 1996
43. Nandi D, Gross JA, Allison JP: CD28-mediated costimulation is necessary for optimal proliferation of murine NK cells. J Immunol 152:3361, 1994
44. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL: Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J Immunol 149:1115, 1992
45. Brunda MJ, Luistro L, Warrier RB, Wright RB, Hubbard BR, Murphy M: Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178:1223, 1993
46. Bonnema JD, Rivlin KA, Ting AT, Schoon RA, Abraham RT, Leibson PJ: Cytokine-enhanced NK cell-mediated cytotoxicity. Positive modulatory effects of IL-2 and IL-12 on stimulus-dependent granule exocytosis. J Immunol 152:2098, 1994
47. Cesano A, Visonneau S, Clark SC, Santoli D: Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J Immunol 151:2943, 1993
48. Kubin M, Kamoun M, Trinchieri G: Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 180:211, 1994
49. Igarashi O, Yanagida T, Azuma M, Okumura K, Nariuchi H: B7-1 synergizes with interleukin-12 in interleukin-2Rα expression by mouse T helper 1 clones. Eur J Immunol 26:300, 1996
50. Rao JB, Chamberlain RS, Bronte V, Carroll MW, Irvine KR, Moss B, Rosenberg SA, Restifo NP: IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines. Enhancement by simultaneous B7-1 expression. J Immunol 156:3357, 1996
51. Duncan GS, Mittrücker H-W, Kägi D, Matsuyama T, Mak TW: The transcription factor interferon regulatory factor-1 is essential for natural killer cell function in vivo. J Exp Med 184:2043, 1996
52. Reiter Z, Rappaport B: Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity. Crit Rev Immunol 13:1, 1993
53. Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G: Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells Eur J Immunol 23:1826, 1993
54. Djeu JU, Blanchard DK: Lysis pf human monocytes by lymphokine-activated killer cells. Cell Immunol 111:55, 1988
55. + cytolytic T cells by suppressing or eliminating dendritic cells. J Immunol 136:3567, 1986
56. Salazar-Mather TP, Ishikawa R, Biron CA: NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J Immunol 157:3054, 1996
57. Kos FJ, Engleman EG: Immune regulation: A critical link between NK cells and CTLs. Immunol Today 17:174, 1996
58. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:985, 1995
59. + cells: The role of CD28 costimulation. Scand J Immunol 44:21, 1996
60. Montel AH, Morse PA, Brahmi Z: Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line. Cell Immunol 160:104, 1994